Given potential impacts of CDKN2B‐AS1 polymorphic genotypes on expression levels of CDKN2B‐AS1 [30], we further analysed correlations of CDKN2B‐AS1 expression levels with clinical significance and survival rates in HCC patients by examining cases from the TCGA‐LIHC dataset. Here, CDKN2B is linked to hepatocellular carcinoma.